SRRA
Sierra Oncology, Inc. Common Stock
SRRA
SRRA
Delisted
SRRA was delisted on the 30th of June, 2022.
70 hedge funds and large institutions have $141M invested in Sierra Oncology, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 14 increasing their positions, 18 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $30K
Holders
70
Holding in Top 10
3
Calls
–
Puts
$30K
Top Buyers
| 1 | +$6.24M | |
| 2 | +$3.8M | |
| 3 | +$1.75M | |
| 4 |
Alkeon Capital Management
New York
|
+$1.13M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$851K |
Top Sellers
| 1 | -$2.77M | |
| 2 | -$2.46M | |
| 3 | -$2.17M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$1.48M |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$1.18M |